REQUEST A DEMO
Total
USD $0.00
Search more companies

Immunicom Europe Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Immunicom Europe Sp. z o.o. Profile Updated: December 13, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Immunicom Europe Sp. z o.o. is a company in Poland, with a head office in Krakow. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. Immunicom Europe Sp. z o.o. was incorporated on March 04, 2021. There was a net sales revenue drop of 41.58% reported in Immunicom Europe Sp. z o.o.’s latest financial highlights for 2024. A growth of 11.89% was recorded in its total assets.

Headquarters
Ul. Zamknieta 10/1.5
Krakow; Malopolskie; Postal Code: 30-554

Contact Details: Purchase the Immunicom Europe Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Immunicom Europe Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Immunicom Europe Sp. z o.o. report to view the information.
Incorporation Date:
March 04, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Immunicom Europe Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-41.58%
Total Operating Revenue
-41.58%
Operating Profit
-63.03%
EBITDA
-63.03%
Net Profit/Loss for the Period
N/A
Total Assets
11.89%
Total Equity
402.36%
Operating Profit Margin
-0.95%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.03%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?